Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Effects of tranylcypromine stereoisomers on monamine oxidation in man.

Literature DB >> 7397067

Effects of tranylcypromine stereoisomers on monamine oxidation in man.

G P Reynolds, W D Rausch, P Riederer.

Abstract

Entities: Chemical Species

Mesh：

Substances：

Year: 1980 PMID： 7397067 PMCID： PMC1429964 DOI： 10.1111/j.1365-2125.1980.tb05852.x

Source DB: PubMed Journal: Br J Clin Pharmacol ISSN： 0306-5251 Impact factor: 4.335

× No keyword cloud information.

6 in total

1. Evidence for dopamine deamination by both type A and type B monoamine oxidase in rat brain in vivo and for the degree of inhibition of enzyme necessary for increased functional activity of dopamine and 5-hydroxytryptamine.

Authors: A R Green; B D Mitchell; A F Tordoff; M B Youdim
Journal: Br J Pharmacol Date: 1977-07 Impact factor: 8.739

2. Comparison of the apparent antidepressant activity of (-) and (+) tranylcypromine in an animal model.

Authors: J A Fuentes; M A Oleshansky; N H Neff
Journal: Biochem Pharmacol Date: 1976-04-01 Impact factor: 5.858

3. The tranylcypromine isomers: a controlled clinical trial.

Authors: J I Escobar; B C Schiele; R Zimmermann
Journal: Am J Psychiatry Date: 1974-09 Impact factor: 18.112

4. Steric requirements for catecholamine uptake by rat brain synaptosomes: studies with rigid analogs of amphetamine.

Authors: A S Horn; S H Snyder
Journal: J Pharmacol Exp Ther Date: 1972-03 Impact factor: 4.030

5. Urinary phenylethylamine excretion: gas chromatographic assay with electron-capture detection of the pentafluorobenzoyl derivative.

Authors: K Blau; I M Claxton; G Ismahan; M Sandler
Journal: J Chromatogr Date: 1979-06-11

6. Tranylcypromine ('Parnate') overdose: measurement of tranylcypromine concentrations and MAO inhibitory activity and identification of amphetamines in plasma.

Authors: M B Youdim; J K Aronson; K Blau; A R Green; D G Grahame-Smith
Journal: Psychol Med Date: 1979-05 Impact factor: 7.723

6 in total

13 in total

Review 1. Neurochemical and metabolic aspects of antidepressants: an overview.

Authors: G B Baker; R T Coutts; A J Greenshaw
Journal: J Psychiatry Neurosci Date: 2000-11 Impact factor: 6.186

Review 2. Insights into the mechanisms of action of the MAO inhibitors phenelzine and tranylcypromine: a review.

Authors: G B Baker; R T Coutts; K F McKenna; R L Sherry-McKenna
Journal: J Psychiatry Neurosci Date: 1992-11 Impact factor: 6.186

Review 3. Kinetics, mechanism, and inhibition of monoamine oxidase.

Authors: Rona R Ramsay; Alen Albreht
Journal: J Neural Transm (Vienna) Date: 2018-03-07 Impact factor: 3.575

4. Tranylcypromine isomers: single-dose effects in normal human subjects.

Authors: C Gorenstein; V Gentil
Journal: Psychopharmacology (Berl) Date: 1981 Impact factor: 4.530

Review 5. Tranylcypromine: new perspectives on an "old" drug.

Authors: Helge Frieling; Stefan Bleich
Journal: Eur Arch Psychiatry Clin Neurosci Date: 2006-08 Impact factor: 5.270

Review 6. The Role of Metabolites of Antidepressants in the Treatment of Depression.

Authors: M V Rudorfer; W Z Potter
Journal: CNS Drugs Date: 1997-04 Impact factor: 5.749

7. Urinary excretion of O-methylated catecholamines, tyramine and phenyl-ethylamine by volunteers treated with tranylcypromine and CGP 11305 A.

Authors: P C Waldmeier; K H Antonin; J J Feldtrauer; C Grunenwald; E Paul; J Lauber; P Bieck
Journal: Eur J Clin Pharmacol Date: 1983 Impact factor: 2.953